← Back to Screener
Kenvue Inc. (KVUE)
Price$17.58
Favorite Metrics
Price vs S&P 500 (26W)-2.98%
Price vs S&P 500 (4W)-8.29%
Market Capitalization$33.75B
P/E Ratio (Annual)22.96x
Indicated Dividend Yield (Annual)4.71%
All Metrics
P/CF (Annual)15.36x
Book Value / Share (Quarterly)$5.62
P/TBV (Annual)15.90x
Indicated Dividend (Annual)$0.83
Revenue Growth (3Y)0.39%
Cash Flow / Share (Quarterly)$0.90
Payout Ratio (TTM)107.55%
Price vs S&P 500 (YTD)-2.05%
Gross Margin (TTM)58.62%
Net Profit Margin (TTM)9.72%
EPS (TTM)$0.76
10-Day Avg Trading Volume18.35M
EPS Excl Extra (TTM)$0.76
Revenue Growth (5Y)0.89%
EPS (Annual)$0.76
Dividend / Share (Annual)$0.83
ROI (Annual)7.62%
Gross Margin (Annual)58.62%
Net Profit Margin (5Y Avg)10.92%
Cash / Share (Quarterly)$0.55
P/E Basic Excl Extra (TTM)22.96x
Revenue Growth QoQ (YoY)3.22%
P/E Normalized (Annual)22.96x
ROA (Last FY)5.43%
Revenue Growth TTM (YoY)-2.14%
EBITD / Share (TTM)$1.54
ROE (5Y Avg)11.91%
Operating Margin (TTM)15.96%
Cash Flow / Share (Annual)$0.90
P/B Ratio3.14x
P/B Ratio (Quarterly)3.06x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)2.73x
Net Interest Coverage (TTM)5.70x
ROA (TTM)5.46%
EPS Growth QoQ (YoY)13.10%
EV / EBITDA (TTM)13.93x
EPS Incl Extra (Annual)$0.76
Current Ratio (Annual)0.96x
Quick Ratio (Quarterly)0.61x
3-Month Avg Trading Volume36.74M
52-Week Price Return-22.53%
EV / Free Cash Flow (Annual)23.93x
P/E Incl Extra (TTM)22.96x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$1.08
P/S Ratio (Annual)2.23x
Asset Turnover (Annual)0.56x
52-Week High$25.17
Operating Margin (5Y Avg)16.32%
EPS Excl Extra (Annual)$0.76
CapEx CAGR (5Y)15.71%
26-Week Price Return5.77%
Quick Ratio (Annual)0.61x
13-Week Price Return2.86%
Total Debt / Equity (Annual)0.79x
Current Ratio (Quarterly)0.96x
Enterprise Value$41,215.652
Revenue / Share Growth (5Y)0.52%
Asset Turnover (TTM)0.56x
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)3.84x
Pretax Margin (Annual)13.22%
Cash / Share (Annual)$0.55
3-Month Return Std Dev20.55%
Gross Margin (5Y Avg)57.11%
Net Income / Employee (TTM)$0
ROE (Last FY)13.66%
Net Interest Coverage (Annual)5.96x
EPS Basic Excl Extra (Annual)$0.76
P/FCF (TTM)19.60x
Receivables Turnover (TTM)6.65x
EV / Free Cash Flow (TTM)23.93x
Total Debt / Equity (Quarterly)0.79x
EPS Incl Extra (TTM)$0.76
Receivables Turnover (Annual)6.65x
ROI (TTM)7.63%
P/S Ratio (TTM)2.23x
Pretax Margin (5Y Avg)14.73%
Revenue / Share (Annual)$7.86
Tangible BV / Share (Annual)$1.08
Forward P/E15.45x
Free OCF CAGR (5Y)-11.48%
Price vs S&P 500 (52W)-57.62%
P/E Ratio (TTM)22.96x
EPS Growth TTM (YoY)42.68%
Year-to-Date Return2.09%
5-Day Price Return2.03%
EPS Normalized (Annual)$0.76
ROA (5Y Avg)6.07%
Net Profit Margin (Annual)9.72%
Month-to-Date Return2.15%
EBITD / Share (Annual)$1.55
EPS Growth (3Y)-11.57%
Operating Margin (Annual)15.96%
LT Debt / Equity (Annual)0.64x
P/CF (TTM)15.36x
ROI (5Y Avg)8.43%
P/E Excl Extra (TTM)22.96x
LT Debt / Equity (Quarterly)0.64x
EPS Basic Excl Extra (TTM)$0.76
P/TBV (Quarterly)15.90x
Payout Ratio (Annual)107.55%
P/B Ratio (Annual)3.06x
Dividend / Share (TTM)$0.83
Inventory Turnover (TTM)3.84x
Pretax Margin (TTM)13.22%
Book Value / Share (Annual)$5.62
Price vs S&P 500 (13W)-0.00%
Dividend Yield (TTM)4.68%
Beta0.58x
P/FCF (Annual)19.60x
Revenue / Share (TTM)$7.87
ROE (TTM)13.94%
52-Week Low$14.02
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.43
2.75
2.75
2.75
Industry Peers — Cosmetics & Toiletries(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
KVUEKenvue Inc. | 2.23x | -2.14% | 58.62% | — | $17.58 |
CLColgate-Palmolive Company | 3.29x | 1.40% | 60.11% | -3.48% | $83.53 |
HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares) | 2.90x | -1.81% | 64.69% | 8.30% | $9.68 |
ELThe Estee Lauder Companies Inc. Class A | 1.89x | -3.35% | 74.33% | — | $77.85 |
ELFe.l.f. Beauty, Inc. | 2.66x | 16.73% | 70.27% | 40.38% | $68.42 |
IPARInterparfums, Inc. Common Stock | 2.12x | 2.49% | 55.46% | 34.17% | $98.01 |
COTYCOTY INC | 1.74x | 9.07% | 63.93% | — | $2.37 |
OLPXOlaplex Holdings, Inc. Common Stock | 3.21x | 0.07% | 70.75% | -20.80% | $2.04 |
EPCEdgewell Personal Care Company | 0.51x | -3.36% | 41.52% | -15.49% | $23.57 |
WALDWaldencast plc Class A Ordinary Share | 0.33x | -0.27% | 68.13% | — | $1.03 |
SLSNSolesence, Inc. Common Stock | 1.42x | 18.56% | 25.88% | -0.79% | $1.22 |
About
Kenvue is the world's largest pure-play consumer health company with over $15 billion in annual revenue, offering products across pain management, oral care, cough and cold care, and skincare through iconic brands including Tylenol, Listerine, Aveeno, and Neutrogena. Spun off from Johnson & Johnson in May 2023, the company agreed to be acquired by Kimberly-Clark in November 2025, with the transaction expected to close in the second half of 2026.